Log In
BCIQ
Print this Print this
 

VM501

  Manage Alerts
Collapse Summary General Information
Company ViroMed Co. Ltd.
DescriptionMutant form of interleukin-11 (IL-11)
Molecular Target Interleukin-11 (IL-11) receptor
Mechanism of ActionInterleukin-11 (IL-11) receptor agonist
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPhase III
Standard IndicationThrombocytopenia
Indication DetailsTreat chemotherapy-induced thrombocytopenia
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today